United States· US:71085-100_4c97e0ed-1d3a-44af-e063-6294a90ae75f
PLIAGLIS
A medicinal product containing lidocaine; tetracaine, registered in United States by IPG PHARMACEUTICALS, INC..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LIDOCAINE; TETRACAINE
- Manufacturer
- IPG PHARMACEUTICALS, INC.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1171085100301 TUBE in 1 CARTON (71085-100-30) / 30 g in 1 TUBE
- ndc1171085-100-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lidocaine; tetracaine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPLIAGLISEgis Pharmaceuticals PLC, Budapešť
- United KingdomPliaglis 70mg/g / 70mg/g creamCroma-Pharma GmbH
- GermanyPliaglisCroma Pharma Gmbh
- NetherlandsPliaglis 70 mg/g + 70 mg/g crèmeCroma Pharma GmbH
- PolandPliaglisEgis Pharmaceuticals PLC
- SwedenRapydan 70 mg/70 mg Medicinskt plåsterEurocept International B.V.
- CanadaPLIAGLISSCIENCES DE LA PEAU CRESCITA INC. / CRESCITA SKIN SCIENCES INC.
- SpainPLIAGLIS 70 MG/G + 70 MG/G CREMAIndustrial Farmaceutica Cantabria S.A.
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Pliaglis, Rapydan
- Belgium · Pliaglis, Rapydan
- Bulgaria · Плиаглис
- Czechia · Pliaglis
- Germany · Pliaglis, Rapydan
- Denmark · Pliapel, Ralydan
- Spain · Pliaglis
- United Kingdom (Northern Ireland) · Pliaglis, Rapydan
- Greece · Pliaglis
- Hungary · Pliapeel
- Ireland · Pliaglis
- Italy · Pliaglis
- Lithuania · Cessolute
- Luxembourg · Pliaglis, Rapydan
- Latvia · Cessolute
- Netherlands · Pliaglis, Rapydan
- Norway · Pliapel, Rapydan
- Poland · Pliaglis
- Portugal · Pliaglis
- Sweden · Rapydan
- Slovakia · Pliaglis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/11d1b52a-701f-463e-acc8-a9048c2c813d GET /v1/drugs/11d1b52a-701f-463e-acc8-a9048c2c813d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "70; 70",
"substance": "LIDOCAINE; TETRACAINE",
"productndc": "71085-100",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "mg/g; mg/g",
"application_number": "NDA021717",
"marketing_category": "NDA"
}See everything about lidocaine; tetracaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.